Aija Knuuttila

1.8k total citations
54 papers, 1.0k citations indexed

About

Aija Knuuttila is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Aija Knuuttila has authored 54 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 21 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Aija Knuuttila's work include Lung Cancer Treatments and Mutations (18 papers), Occupational and environmental lung diseases (13 papers) and Pleural and Pulmonary Diseases (10 papers). Aija Knuuttila is often cited by papers focused on Lung Cancer Treatments and Mutations (18 papers), Occupational and environmental lung diseases (13 papers) and Pleural and Pulmonary Diseases (10 papers). Aija Knuuttila collaborates with scholars based in Finland, Denmark and Norway. Aija Knuuttila's co-authors include Virinder Kaur Sarhadi, Sakari Knuutila, Jari Räsänen, K. Mattson, Eero Sihvo, Mikko Rönty, Jarmo Salo, Kaisa Salmenkivi, Ilkka Ilonen and L. Kivisaari and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Aija Knuuttila

51 papers receiving 1.0k citations

Peers

Aija Knuuttila
Aija Knuuttila
Citations per year, relative to Aija Knuuttila Aija Knuuttila (= 1×) peers Seiichi Kakegawa

Countries citing papers authored by Aija Knuuttila

Since Specialization
Citations

This map shows the geographic impact of Aija Knuuttila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aija Knuuttila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aija Knuuttila more than expected).

Fields of papers citing papers by Aija Knuuttila

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aija Knuuttila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aija Knuuttila. The network helps show where Aija Knuuttila may publish in the future.

Co-authorship network of co-authors of Aija Knuuttila

This figure shows the co-authorship network connecting the top 25 collaborators of Aija Knuuttila. A scholar is included among the top collaborators of Aija Knuuttila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aija Knuuttila. Aija Knuuttila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ashraf, Haseem, et al.. (2025). Adherence to guidelines for incidental pulmonary nodules: insights from a Nordic survey. Acta Oncologica. 64. 22–26.
2.
Verbiest, Annelies, Ilkka Ilonen, Michael Franz, et al.. (2025). 1867P FALCON-Lung: Evolving global ICI treatment patterns and outcomes in the era of personalized mNSCLC treatment. Annals of Oncology. 36. S1004–S1004. 1 indexed citations
3.
Mäyränpää, Mikko I., Swapnil Potdar, Jie Bao, et al.. (2021). Functional diagnostics using fresh uncultured lung tumor cells to guide personalized treatments. Cell Reports Medicine. 2(8). 100373–100373. 3 indexed citations
4.
Vesterinen, Tiina, Kaisa Salmenkivi, Harri Mustonen, et al.. (2019). Performance of Finnish biobanks in nationwide pulmonary carcinoid tumour research. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 476(2). 273–283. 3 indexed citations
5.
Iivanainen, Sanna, et al.. (2019). Elevated CRP levels indicate poor progression-free and overall survival on cancer patients treated with PD-1 inhibitors. ESMO Open. 4(4). e000531–e000531. 67 indexed citations
6.
Youssef, Omar, Aija Knuuttila, Päivi Piirilä, et al.. (2018). Hotspot Mutations Detectable by Next-generation Sequencing in Exhaled Breath Condensates from Patients with Lung Cancer. Anticancer Research. 38(10). 5627–5634. 18 indexed citations
7.
Youssef, Omar, Aija Knuuttila, Päivi Piirilä, et al.. (2017). Presence of cancer-associated mutations in exhaled breath condensates of healthy individuals by next generation sequencing. Oncotarget. 8(11). 18166–18176. 20 indexed citations
8.
Sarhadi, Virinder Kaur, Mikko Rönty, Eeva Kettunen, et al.. (2016). Hot spot mutations in Finnish non-small cell lung cancers. Lung Cancer. 99. 102–110. 19 indexed citations
10.
Rönty, Mikko, et al.. (2014). Epidermal Growth Factor Receptor Mutations in 510 Finnish Non–Small-Cell Lung Cancer Patients. Journal of Thoracic Oncology. 9(6). 886–891. 19 indexed citations
11.
Salmenkivi, Kaisa & Aija Knuuttila. (2014). [Diagnostics of non-small cell lung carcinoma].. PubMed. 130(7). 701–4. 1 indexed citations
13.
Kivelä, Antti, Aija Knuuttila, Jari Räsänen, et al.. (2012). Carbonic anhydrase IX in malignant pleural mesotheliomas: A potential target for anti-cancer therapy. Bioorganic & Medicinal Chemistry. 21(6). 1483–1488. 10 indexed citations
14.
Ilonen, Ilkka, Jari Räsänen, Aija Knuuttila, et al.. (2010). Quality of life following lobectomy or bilobectomy for non-small cell lung cancer, a two-year prospective follow-up study. Lung Cancer. 70(3). 347–351. 38 indexed citations
15.
Ilonen, Ilkka, Jari Räsänen, Eero Sihvo, et al.. (2009). Oxidative stress in non-small cell lung cancer: Role of nicotinamide adenine dinucleotide phosphate oxidase and glutathione. Acta Oncologica. 48(7). 1054–1061. 20 indexed citations
16.
Sihto, Harri, Marjut Puputti, Olli Tynninen, et al.. (2005). Epidermal growth factor receptor domain II, IV, and kinase domain mutations in human solid tumors. Journal of Molecular Medicine. 83(12). 976–983. 25 indexed citations
17.
Ollikainen, Tiina, Aija Knuuttila, Satu Suhonen, et al.. (2000). In vitro sensitivity of normal human mesothelial and malignant mesothelioma cell lines to four new chemotherapeutic agents. Anti-Cancer Drugs. 11(2). 93–99. 22 indexed citations
18.
Knuuttila, Aija, Maija Halme, M Mäntylä, et al.. (1999). Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cancer. Annals of Oncology. 10(9). 1059–1064. 33 indexed citations
19.
Knuuttila, Aija, et al.. (1998). The clinical importance of magnetic resonance imaging versus computed tomography in malignant pleural mesothelioma. Lung Cancer. 22(3). 215–225. 27 indexed citations
20.
Alanko, Kristiina, Aija Knuuttila, Jukka Laitinen, et al.. (1998). Comparison of a Multidose Powder Inhaler Containing Beclomethasone Dipropionate (BDP) with a BDP Metered Dose Inhaler with Spacer in the Treatment of Asthmatic Patients. Clinical Drug Investigation. 16(2). 101–110. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026